Quick Answer
Harmony Biosciences Holdings, Inc. reported Stockholders Equity of $870.22 million for fiscal year 2025.
Harmony Biosciences Holdings, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $870.22M | +32.0% |
| 2024 | $659.15M | +41.1% |
| 2023 | $466.99M | +15.9% |
| 2022 | $402.84M | +116.0% |
| 2021 | $186.51M | +91.9% |
| 2020 | $97.18M | +123.0% |
| 2019 | -$422.86M | -74.3% |
| 2018 | -$242.67M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $835.12M | +39.9% | +8.0% |
| June 30, 2025 | $773.08M | +43.5% | +7.3% |
| March 31, 2025 | $720.52M | +39.8% | +9.3% |
| December 31, 2024 | $659.15M | +41.1% | +10.4% |
| September 30, 2024 | $596.80M | +24.0% | +10.8% |
| June 30, 2024 | $538.58M | +11.0% | +4.5% |
| March 31, 2024 | $515.39M | +16.3% | +10.4% |
| December 31, 2023 | $466.99M | +15.9% | -3.0% |
- Harmony Biosciences Holdings, Inc. showed an increase of +32.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Harmony Biosciences Holdings, Inc.’s stockholders equity has grown by 458.6% (from -$242.67 million to $870.22 million).
- The most recent figure is from Harmony Biosciences Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: